Lymph node ratio is a better prognosticator than lymph node status for gastric cancer: A retrospective study of 138 cases

Oncology Letters

Volumn 6, Issue 6, 2013, Pages 1693-1700

  Zeng, Wei Juan ^a   Hu, Wen Qin ^b   Wang, Lin Wei ^a   Yan, Shu Guang ^b   Li, Jian Ding ^c   Zhao, Hao Liang ^d   Peng, Chun Wei ^a   Yang, Gui Fang ^a   Li, Yan ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b CHANGZHI MEDICAL COLLEGE   (China)

^c SHANXI MEDICAL UNIVERSITY   (China)

^d SHANXI UNIVERSITY   (China)

Author keywords

Gastric cancer; Lymph node ratio; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER STAGING; FEMALE; GASTRECTOMY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTIVE VALUE; RETROSPECTIVE STUDY; STOMACH CANCER; TUMOR INVASION;

EID: 84886782902     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1615     Document Type: Article

References (31)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
3. Yang L: Incidence and mortality of gastric cancer in China. World J Gastroenterol 12: 17-20, 2006.
4. Hartgrink HH, Jansen EP, van Grieken NC and van de Velde CJ: Gastric cancer. Lancet 374: 477-490, 2009.
5. Wang XN and Liang H: Some problems in the surgical treatment of gastric cancer. Chin J Cancer 29: 369-373, 2010.
6. Viudez-Berral A, Miranda-Murua C and Arias-de-la-Vega F, et al: Current management of gastric cancer. Rev Esp Enferm Dig 104: 134-141, 2012.
7. Lee JH, Kim KM, Cheong JH and Noh SH: Current management and future strategies of gastric cancer. Yonsei Med J 53: 248-257, 2012.
8. Wu HL, Tian Q, Peng CW, Liu SP and Li Y: Multivariate survival and outcome analysis of 154 patients with gastric cancer at a single Chinese institution. Asian Pac J Cancer Prev 12: 3341-3345, 2011.
9. Landry CS, Brock G, Scoggins CR, McMasters KM and Martin RN II: A proposed staging system for gastric carcinoid tumors based on an analysis of 1,543 patients. Ann Surg Oncol 16: 51-60, 2009.
10. Cammerer G, Formentini A, Karletshofer M, Henne-Bruns D and Kornmann M: Evaluation of important prognostic clinical and pathological factors in gastric cancer. Anticancer Res 32: 1839-1842, 2012.
11. Washington K: 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol 17: 3077-3079, 2010.
12. Sun Z, Wang ZN and Zhu Z, et al: Evaluation of the seventh edition of American Joint Committee on Cancer TNM staging system for gastric cancer: results from a Chinese monoinstitutional study. Ann Surg Oncol 19: 1918-1927, 2012.
13. Chae S, Lee A and Lee JH: The effectiveness of the new (7th) UICC N classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 5th/6th and 7th UICC N classification. Gastric Cancer 14: 166-171, 2011.
14. Ahn HS, Lee HJ and Hahn S, et al: Evaluation of the seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification. Cancer 116: 5592-5598, 2010.
15. Wang W, Sun XW and Li CF, et al: Comparison of the 6th and 7th editions of the UICC TNM staging system for gastric cancer: results of a Chinese single-institution study of 1,503 patients. Ann Surg Oncol 18: 1060-1067, 2011.
16. Kim SS, Choi BY, Seo SI, et al: The comparison between 6th and 7th International Union Against Cancer/American Joint Committee on Cancer Classification for Survival Prognosis of Gastric Cancer. Korean J Gastroenterol 58: 258-263, 2011 (In Korean).
17. Wang W, Xu DZ and Li YF, et al: Tumor-ratio-metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection-results of a single-institution study of 1343 Chinese patients. Ann Oncol 22: 2049-2056, 2011.
18. Wang J, Dang P and Raut CP, et al: Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. Ann Surg 255: 478-485, 2012.
19. Lee SR, Kim HO, Son BH, Shin JH and Yoo CH: Prognostic significance of the metastatic lymph node ratio in patients with gastric cancer. World J Surg 36: 1096-1101, 2012.
20. Liu X, Cai H, Shi Y and Wang Y: Prognostic factors in patients with node-negative gastric cancer: a single center experience from China. J Gastrointest Surg 16: 1123-1127, 2012.
21. Diaz de Liaño A, Yarnoz C, Aguilar R, Artieda C and Ortiz H: Rationale for gastrectomy with D2 lymphadenectomy in the treatment of gastric cancer. Gastric Cancer 11: 96-102, 2008.
22. D'Annibale A, Pende V, Pernazza G, et al: Full robotic gastrectomy with extended (D2) lymphadenectomy for gastric cancer: surgical technique and preliminary results. J Surg Res 166: 113-120, 2011.
23. Kim CY and Yang DH: Adjustment of N stages of gastric cancer by the ratio between the metastatic and examined lymph nodes. Ann Surg Oncol 16: 1868-1874, 2009.
24. Asoglu O, Karanlik H and Parlak M, et al: Metastatic lymph node ratio is an independent prognostic factor in gastric cancer. Hepatogastroenterology 56: 908-913, 2009.
25. Xu DZ, Geng QR and Long ZJ, et al: Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes. Ann Surg Oncol 16: 319-326, 2009.
26. Lee SY, Hwang I, Park YS, Gardner J and Ro JY: Metastatic lymph node ratio in advanced gastric carcinoma: A better prognostic factor than number of metastatic lymph nodes? Int J Oncol 36: 1461-1467, 2010.
27. Huang CM, Lin JX and Zheng CH, et al: Prognostic impact of metastatic lymph node ratio on gastric cancer after curative distal gastrectomy. World J Gastroenterol 16: 2055-2060, 2010.
28. Feng J, Wu YF, Xu HM, Wang SB and Chen JQ: Prognostic significance of the metastatic lymph node ratio in T3 gastric cancer patients undergoing total gastrectomy. Asian Pac J Cancer Prev 12: 3289-3292, 2011.
29. Lemmens V, Dassen AE, van der Wurff A, Coebergh J and Bosscha K: Lymph node examination among patients with gastric cancer: variation between departments of pathology and prognostic impact of lymph node ratio. Eur J Surg Oncol 37: 488-496, 2011.
30. Qiu MZ, Qiu HJ and Wang ZQ, et al: The tumor-log odds of positive lymph nodes-metastasis staging system, a promising new staging system for gastric cancer after D2 resection in China. PLoS One 7: e31736, 2012.
31. Peng CW, Wang LW, zeng WJ, Yang XJ and Li Y: Evaluation of the staging system for gastric cancer. J Surg Oncol 108: 93-105, 2013.